Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Barcelona Institute of Science and Technology
Barcelona, EspañaPublications in collaboration with researchers from Barcelona Institute of Science and Technology (11)
2024
2023
-
Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV)
Bone Marrow Transplantation
2022
-
A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
Cell Metabolism, Vol. 34, Núm. 6, pp. 857-873.e9
2021
-
The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation
Cell Metabolism, Vol. 33, Núm. 2, pp. 379-394.e8
2020
-
Epigenetic SmAd3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma
Cancer Research, Vol. 80, Núm. 2, pp. 276-290
-
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Cell, Vol. 181, Núm. 4, pp. 905-913.e7
2019
2017
-
NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma
Oncotarget, Vol. 8, Núm. 25, pp. 40967-40981
2014
-
Heterogeneous micromechanical properties of the extracellular matrix in healthy and infarcted hearts
Acta Biomaterialia, Vol. 10, Núm. 7, pp. 3235-3242
2013
-
PrPC regulates epidermal growth factor receptor function and cell shape dynamics in Neuro2a cells
Journal of Neurochemistry, Vol. 127, Núm. 1, pp. 124-138